Drug Discovery Informatics Market to reach USD 8.12 billion by 2032 and grow at a CAGR of 11.16%.
The global drug discovery informatics market is experiencing robust growth because of development in high-performance computing and an increasing number of demands for innovative molecules of drugs. Other factors of this growth include an expanded volume of drug discovery data and more intense market competition. For instance, in 2021 the company, Certara, Inc., brought out the latest version of the PBPK Simulator - Simcyp Physiologically-based Pharmacokinetic (Simcyp PBPK), designed with newly added models on pregnant and lactating women drug interactions. These innovations will thus optimize how drug safety and efficacy may be enhanced toward a heightened impact on informatics.